No Time to Wait

As a result of the pandemic some pancreatic cancer treatment was delayed by up to two months. With more than half of people dying within three months of diagnosis, pancreatic cancer was a cancer emergency before the pandemic. Even short delays between diagnosis and treatment can drastically lower survival rates for the 10,000 people diagnosed each year. That’s why we launched our No Time to Wait campaign.

Bryony’s story

Our impact

But thanks to your support for the No Time to Wait campaign we had a huge impact. With your support we were able to change the priority pancreatic cancer was given throughout the pandemic. With over 62,000 of you calling on NHS decision makers to take action, and 800 supporters contacting their parliamentarians, we were able to influence 89% of NHS bodies across the to publish their plans to restore their pancreatic cancer services.

The No Time to Wait campaign led to us being given a seat at the table at the NHS England Cancer recovery taskforce, having influence over decisions around healthcare provision at a national level. This was a major breakthrough for the profile of pancreatic cancer. Our contact with NHS bodies also enabled us to identify and disseminate best practice to those treating people with pancreatic cancer ahead of the second wave.

Following our open letter calling for urgent action, we met with Jo Churchill, the minister with responsibility for cancer in England, about the impact of the pandemic on pancreatic cancer.

Thank you to everyone who took a stand with us to make sure people with pancreatic cancer weren’t left waiting for treatment.